Immunology and Microbiology
Poliomyelitis Virus
100%
Human Respiratory Syncytial Virus
45%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Influenza
24%
Enterovirus
23%
Immunology
23%
Human Poliovirus 2
18%
Lower Respiratory Tract
18%
Prevalence
17%
Infectious Agent
17%
Neutralizing Antibody
16%
Cladistics
15%
Human Immunodeficiency Virus
15%
Lineages
13%
Serotype
11%
Next Generation Sequencing
10%
Neutralization
10%
Oral Poliomyelitis Vaccine
10%
Dynamics
10%
Yellow Fever
9%
Viral Load
9%
Human Poliovirus 1
9%
Evolution
9%
Wild Type
8%
Virus Evolution
8%
Molecular Epidemiology
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Disease Burden
8%
Virus Isolation
7%
Human Immunodeficiency Virus 1
7%
Schistosomiasis
7%
Yellow Fever Vaccine
7%
Antibody Response
7%
Echovirus 9
7%
Helminthiasis
7%
Genomic Surveillance
7%
Bird
7%
Population Dynamics
7%
Hepatitis B Virus
7%
Hepatitis Delta Virus
7%
Hepatitis B
7%
Virus Neutralization
7%
Viral Disease
7%
Enterovirus B
7%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
39%
Poliomyelitis Virus
30%
Flaccid Paralysis
29%
Human Poliovirus 2
26%
Respiratory Tract Infection
23%
Infection
22%
Human Respiratory Syncytial Virus
22%
Poliomyelitis
22%
Medical Research
20%
Yellow Fever
16%
Pathogen
12%
Disease
12%
Molecular Diagnosis
11%
Surveillance System
10%
Oral Poliomyelitis Vaccine
9%
COVID-19
9%
Next Generation Sequencing
8%
Influenza
8%
Toddlers
8%
Cross Sectional Study
8%
Diagnosis
8%
Public Health
7%
Lower Respiratory Tract Infection
7%
Coronavirinae
7%
Enterovirus D68
7%
Drug Resistance
7%
Bacterial Infection
7%
Avian Influenza
7%
Disease Burden
7%
Resistance Mutation
7%
Radiation Therapy
7%
Yellow Fever Virus
7%
Malignant Neoplasm
7%
Yellow Fever Vaccine
7%
Antibody Response
7%
Human Immunodeficiency Virus
7%
Evolution
7%
Lassa Fever
7%
Cohort Effect
7%
Adverse Event
6%
Coughing
6%
Paralysis
5%
Phylogeny
5%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
37%
Poliomyelitis Virus
32%
Flaccid Paralysis
28%
Poliomyelitis
28%
Human Poliovirus 2
25%
SARS Coronavirus
18%
Lower Respiratory Tract Infection
17%
Respiratory Tract Infection
15%
Disease
12%
HIV
10%
Virus Infection
9%
Oral Poliomyelitis Vaccine
9%
Yellow Fever
9%
Lassa Fever
9%
Procyanidin
7%
Cacao
7%
Enterovirus D68
7%
Human Immunodeficiency Virus 1
7%
Drug Resistance
7%
Repurposing
7%
Yellow Fever Vaccine
7%
Enterovirus
7%
Schistosomiasis
7%
Helminthiasis
7%
Adverse Event
6%
Paralysis
5%
Diseases
5%
Infection
5%